Extra Time on Brazilian College Level Exam for Students With and Without ADHD
Launched by HOSPITAL DE CLINICAS DE PORTO ALEGRE · Sep 29, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether giving extra time on exams, like the Brazilian National High School Exam (ENEM), helps students with Attention Deficit Hyperactivity Disorder (ADHD) perform better. The study wants to find out if this extra time also benefits students without ADHD and if it helps those with specific traits. They are currently recruiting participants who are Brazilian citizens and planning to take college-entry standardized tests.
To be eligible for the study, participants must be between 5843 and 14609 days old (which roughly translates to ages 16 to 40) and must not have any serious medical conditions, intellectual disabilities, or serious mental health issues that could affect their ability to participate. If you join the trial, you can expect to take part in standardized testing with extra time and help researchers understand how this affects test performance for different students. Your participation could contribute valuable information about how to support students in educational settings.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Brazilian citizen;
- • Planing to participate in college-entry standardized tests (ENEM, Vestibulares);
- Exclusion Criteria:
- • Medical condition and/or disability that may hinder the neuropsychological testing;
- • Intelligence Quotient (IQ) lower than 80;
- • Psychotic disorders, bipolar disorders, current moderate or severe depressive episode, suicide risk, autism spectrum disorders, learning disabilities.
About Hospital De Clinicas De Porto Alegre
Hospital de Clínicas de Porto Alegre (HCPA) is a leading academic medical center in Brazil, renowned for its commitment to advancing healthcare through innovative clinical research. As a sponsor of clinical trials, HCPA leverages its extensive expertise in various medical disciplines to conduct rigorous studies aimed at improving patient outcomes and contributing to the global medical community. With a multidisciplinary team of skilled professionals and state-of-the-art facilities, HCPA fosters a collaborative environment that prioritizes ethical standards, patient safety, and scientific integrity in all its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Porto Alegre, Rio Grande Do Sul, Brazil
Patients applied
Trial Officials
Luis Augusto Paim Rohde, PhD
Principal Investigator
Hospital de Clínicas de Porto Alegre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported